Change history
24 February 2021
A Correction to this paper has been published: https://doi.org/10.1007/s12079-020-00583-2
References
Allen MP, Zeng C, Schneider K, Xiong X, Meintzer MK, Bellosta P, Basilico C, Varnum B, Heidenreich KA, Wierman ME (1999) Growth arrest-specific gene 6 (Gas6)/adhesion related kinase (Ark) signaling promotes gonadotropin-releasing hormone neuronal survival via extracellular signal-regulated kinase (ERK) and Akt. Mol Endocrinol 13:191–201
Allen MP, Xu M, Linseman DA, Pawlowski JE, Bokoch GM, Heidenreich KA, Wierman ME (2002) Adhesion-related kinase repression of gonadotropin-releasing hormone gene expression requires Rac activation of the extracellular signal-regulated kinase pathway. J Biol Chem 277:38133–38140
Barcena C, Stefanovic M, Tutusaus A, Joannas L, Menendez A, Garcia-Ruiz C, Sancho-Bru P, Mari M, Caballeria J, Rothlin CV, Fernandez-Checa JC, De Frutos PG, Morales A (2015) Gas6/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation. J Hepatol 63:670–678
Bellan M, Pirisi M, Sainaghi PP (2016) The Gas6/TAM system and multiple sclerosis. Int J Mol Sci 17
Berk BC (2001) Vascular smooth muscle growth: autocrine growth mechanisms. Physiol Rev 81:999–1030
Bertin FR, Lemarie CA, Robins RS, Blostein MD (2015) Growth arrest-specific 6 regulates thrombin-induced expression of vascular cell adhesion molecule-1 through forkhead box O1 in endothelial cells. J Thromb Haemost 13:2260–2272
Brien FS (1964) Desirable standards for clinical tests of drugs. Chemotherapia (Basel) 9:220–222
Brown JE, Krodel M, Pazos M, Lai C, Prieto AL (2012) Cross-phosphorylation, signaling and proliferative functions of the Tyro3 and Axl receptors in Rat2 cells. PLoS One 7:e36800
Cavet ME, Smolock EM, Menon P, Konishi A, Korshunov VA, Berk BC (2010) Gas6-Axl pathway: the role of redox-dependent association of Axl with nonmuscle myosin IIB. Hypertension 56:105–111
Chen YL, Tsai YT, Chao TT, Wu YN, Chen MC, Lin YH, Liao CH, Chou SP, Chiang HS (2018) DAPK and CIP2A are involved in GAS6/AXL-mediated Schwann cell proliferation in a rat model of bilateral cavernous nerve injury. Oncotarget 9:6402–6415
Collett GD, Sage AP, Kirton JP, Alexander MY, Gilmore AP, Canfield AE (2007) Axl/phosphatidylinositol 3-kinase signaling inhibits mineral deposition by vascular smooth muscle cells. Circ Res 100:502–509
De Polo A, Luo Z, Gerarduzzi C, Chen X, Little JB, Yuan ZM (2017) AXL receptor signalling suppresses p53 in melanoma through stabilization of the MDMX-MDM2 complex. J Mol Cell Biol 9:154–165
Demarchi F, Verardo R, Varnum B, Brancolini C, Schneider C (2001) Gas6 anti-apoptotic signaling requires NF-kappa B activation. J Biol Chem 276:31738–31744
Dey G, Radhakrishnan A, Syed N, Thomas JK, Nadig A, Srikumar K, Mathur PP, Pandey A, Lin SK, Raju R, Prasad TS (2013) Signaling network of Oncostatin M pathway. J Cell Commun Signal 7:103–108
Elkabets M, Pazarentzos E, Juric D, Sheng Q, Pelossof RA, Brook S, Benzaken AO, Rodon J, Morse N, Yan JJ, Liu M, Das R, Chen Y, Tam A, Wang H, Liang J, Gurski JM, Kerr DA, Rosell R, Teixido C, Huang A, Ghossein RA, Rosen N, Bivona TG, Scaltriti M, Baselga J (2015) AXL mediates resistance to PI3Kalpha inhibition by activating the EGFR/PKC/mTOR axis in head and neck and esophageal squamous cell carcinomas. Cancer Cell 27:533–546
Fiebeler A, Park JK, Muller DN, Lindschau C, Mengel M, Merkel S, Banas B, Luft FC, Haller H (2004) Growth arrest specific protein 6/Axl signaling in human inflammatory renal diseases. Am J Kidney Dis 43:286–295
Hong CC, Lay JD, Huang JS, Cheng AL, Tang JL, Lin MT, Lai GM, Chuang SE (2008) Receptor tyrosine kinase AXL is induced by chemotherapy drugs and overexpression of AXL confers drug resistance in acute myeloid leukemia. Cancer Lett 268:314–324
Jin CW, Wang H, Chen YQ, Tang MX, Fan GQ, Wang ZH, Li L, Zhang Y, Zhang W, Zhong M (2015) Gas6 delays senescence in vascular smooth muscle cells through the PI3K/ Akt/FoxO signaling pathway. Cell Physiol Biochem 35:1151–1166
Kandasamy K, Keerthikumar S, Raju R, Prasad K, Ramachandra TS, Mohan YLS, & Pandey A (2009) PathBuilder–open source software for annotating and developing pathway resources. Bioinformatics 25:2860–2862
Kandasamy K, Mohan SS, Raju R, Keerthikumar S, Kumar GS, Venugopal AK, Telikicherla D, Navarro JD, Mathivanan S, Pecquet C, Gollapudi SK, Tattikota SG, Mohan S, Padhukasahasram H, Subbannayya Y, Goel R, Jacob HK, Zhong J, Sekhar R, Nanjappa V, Balakrishnan L, Subbaiah R, Ramachandra YL, Rahiman BA, Prasad TS, Lin JX, Houtman JC, Desiderio S, Renauld JC, Constantinescu SN, Ohara O, Hirano T, Kubo M, Singh S, Khatri P, Draghici S, Bader GD, Sander C, Leonard WJ, Pandey A (2010) NetPath: a public resource of curated signal transduction pathways. Genome Biol 11:R3
Konishi A, Aizawa T, Mohan A, Korshunov VA, Berk BC (2004) Hydrogen peroxide activates the Gas6-Axl pathway in vascular smooth muscle cells. J Biol Chem 279:28766–28770
Korshunov VA (2012) Axl-dependent signalling: a clinical update. Clin Sci (Lond) 122:361–368
Laurance S, Aghourian MN, Lila ZJ, Lemarie, C. A. & Blostein MD (2014) Gas6-induced tissue factor expression in endothelial cells is mediated through caveolin-1-enriched microdomains. J Thromb Haemost 12:395–408
Leconet W, Larbouret C, Chardes T, Thomas G, Neiveyans M, Busson M, Jarlier M, Radosevic-Robin N, Pugniere M, Bernex F, Penault-Llorca F, Pasquet JM, Pelegrin A, Robert B (2014) Preclinical validation of AXL receptor as a target for antibody-based pancreatic cancer immunotherapy. Oncogene 33:5405–5414
Lemke G (2013) Biology of the TAM receptors. Cold Spring Harb Perspect Biol 5:a009076
Lemke G, Rothlin CV (2008) Immunobiology of the TAM receptors. Nat Rev Immunol 8:327–336
Li Y, Jia L, Ren D, et al. Axl mediates tumor invasion and chemosensitivity through PI3K/Akt signaling pathway and is transcriptionally regulated by slug in breast carcinoma. IUBMB Life. 2014;66(7):507–518. https://doi.org/10.1002/iub.1285
Li Y, Wang X, Bi S, Zhao K, Yu C (2015) Inhibition of Mer and Axl receptor tyrosine kinases leads to increased apoptosis and improved chemosensitivity in human neuroblastoma. Biochem Biophys Res Commun 457:461–466
Linger RM, Keating AK, Earp HS, Graham DK (2008) TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer. Adv Cancer Res 100:35–83
Linger RM, Keating AK, Earp HS, Graham DK (2010) Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors. Expert Opin Ther Targets 14:1073–1090
Linz U, Schleithoff L, Janssen JW, Bartram CR, Muller CR (1993) A PvuII-polymorphism within the AXL gene on chromosome 19q13.1. Hum Mol Genet 2:492
Mahadevan D, Cooke L, Riley C, Swart R, Simons B, Della Croce K, Wisner L, Iorio M, Shakalya K, Garewal H, Nagle R, Bearss D (2007) A novel tyrosine kinase switch is a mechanism of imatinib resistance in gastrointestinal stromal tumors. Oncogene 26:3909–3919
Martinelli E, Martini G, Cardone C, Troiani T, Liguori G, Vitagliano D, Napolitano S, Morgillo F, Rinaldi B, Melillo RM, Liotti F, Nappi A, Bianco R, Berrino L, Ciuffreda LP, Ciardiello D, Iaffaioli V, Botti G, Ferraiolo F, Ciardiello F (2015) AXL is an oncotarget in human colorectal cancer. Oncotarget 6:23281–23296
Myers KV, Amend SR, Pienta KJ (2019) Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment. Mol Cancer 18:94
Nielsen-Preiss SM, Allen MP, Xu M, Linseman DA, Pawlowski JE, Bouchard RJ, Varnum BC, Heidenreich KA, Wierman ME (2007) Adhesion-related kinase induction of migration requires phosphatidylinositol-3-kinase and ras stimulation of rac activity in immortalized gonadotropin-releasing hormone neuronal cells. Endocrinology 148:2806–2814
Nieto MA, Huang RY, Jackson RA, Thiery JP (2016) Emt: 2016. Cell 166:21–45
O’bryan JP, Frye RA, Cogswell PC, Neubauer A, Kitch B, Prokop C, Espinosa R III, Le Beau MM, Earp HS, Liu ET (1991) axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase. Mol Cell Biol 11:5016–5031
Pao-Chun L, Chan PM, Chan W, Manser E (2009) Cytoplasmic ACK1 interaction with multiple receptor tyrosine kinases is mediated by Grb2: an analysis of ACK1 effects on Axl signaling. J Biol Chem 284:34954–34963
Pinto SM, Subbannayya Y, Rex DaB, Raju R, Chatterjee O, Advani J, Radhakrishnan A, Prasad TSK, Wani, M. R. & Pandey A (2018) A network map of IL-33 signaling pathway. J Cell Commun Signal 12:615–624
Raju R, Palapetta SM, Sandhya VK, Sahu A, Alipoor A, Balakrishnan L, Advani J, George B, Kini KR, Geetha NP, Prakash HS, Prasad TS, Chang YJ, Chen L, Pandey A, Gowda H (2014) A Network Map of FGF-1/FGFR Signaling System. J Signal Transduct 2014:962962
Rex DaB, Agarwal N, Prasad TSK, Kandasamy RK, Subbannayya Y, Pinto SM (2020) A comprehensive pathway map of IL-18-mediated signalling. J Cell Commun Signal 14:257–266
Sahu A, Gopalakrishnan L, Gaur N, Chatterjee O, Mol P, Modi PK, Dagamajalu S, Advani J, Jain S, Keshava Prasad TS (2018) The 5-Hydroxytryptamine signaling map: an overview of serotonin-serotonin receptor mediated signaling network. J Cell Commun Signal 12:731–735
Sainaghi PP, Bellan M, Lombino F, Alciato F, Carecchio M, Galimberti D, Fenoglio C, Scarpini E, Cantello R, Pirisi M, Comi C (2017) Growth Arrest Specific 6 Concentration is Increased in the Cerebrospinal Fluid of Patients with Alzheimer’s Disease. J Alzheimers Dis 55:59–65
Sandhya VK, Raju R, Verma R, Advani J, Sharma R, Radhakrishnan A, Nanjappa V, Narayana J, Somani BL, Mukherjee KK, Pandey A, Christopher R, Prasad TS (2013) A network map of BDNF/TRKB and BDNF/p75NTR signaling system. J Cell Commun Signal 7:301–307
Sasaki T, Knyazev PG, Clout NJ, Cheburkin Y, Gohring W, Ullrich A, Timpl R, Hohenester E (2006) Structural basis for Gas6-Axl signalling. EMBO J 25:80–87
Tai KY, Shieh YS, Lee CS, Shiah SG, Wu CW (2008) Axl promotes cell invasion by inducing MMP-9 activity through activation of NF-kappaB and Brg-1. Oncogene 27:4044–4055
Thiery JP, Acloque H, Huang RY, Nieto MA (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139:871–890
Tian Y, Zhang Z, Miao L, Yang Z, Yang J, Wang Y, Qian D, Cai H (2016) Anexelekto (AXL) Increases Resistance to EGFR-TKI and Activation of AKT and ERK1/2 in Non-Small Cell Lung Cancer Cells. Oncol Res 24:295–303
Verma R, Balakrishnan L, Sharma K, Khan AA, Advani J, Gowda H, Tripathy SP, Suar M, Pandey A, Gandotra S, Prasad TS, Shankar S (2016) A network map of Interleukin-10 signaling pathway. J Cell Commun Signal 10:61–67
Xiao Y, Zhao H, Tian L, Nolley R, Diep AN, Ernst A, Fuh KC, Miao YR, Von Eyben R, Leppert JT, Brooks JD, Peehl DM, Giaccia AJ, Rankin EB (2019) S100A10 Is a Critical Mediator of GAS6/AXL-Induced Angiogenesis in Renal Cell Carcinoma. Cancer Res 79:5758–5768
Yanagita M, Ishii K, Ozaki H, Arai H, Nakano T, Ohashi K, Mizuno K, Kita T, Doi T (1999) Mechanism of inhibitory effect of warfarin on mesangial cell proliferation. J Am Soc Nephrol 10:2503–2509
Zhao YF, Xu DC, Zhu GF, Zhu MY, Tang K, Li WM, Xu YW (2016) Growth arrest-specific 6 exacerbates pressure overload-induced cardiac hypertrophy. Hypertension 67:118–29
Zhou L, Liu XD, Sun M, Zhang X, German P, Bai S, Ding Z, Tannir N, Wood CG, Matin SF, Karam JA, Tamboli P, Sircar K, Rao P, Rankin EB, Laird DA, Hoang AG, Walker CL, Giaccia AJ, Jonasch E (2016) Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma. Oncogene 35:2687–2697
Acknowledgements
We thank Karnataka Biotechnology and Information Technology Services (KBITS), Government of Karnataka, for the support to Center for Systems Biology and Molecular Medicine at Yenepoya (Deemed to be University) under the Biotechnology Skill Enhancement Programme in Multiomics Technology (BiSEP GO ITD 02 MDA 2017). RDAB is a recipient of the Senior Research Fellowship from the Indian Council of Medical Research (ICMR), Government of India. AP is a recipient of the Junior Research Fellowship from the University Grants Commission (UGC), Government of India.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors report no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
A compendium of AXL-mediated signaling events. (XLSX 163 KB)
Rights and permissions
About this article
Cite this article
Dagamajalu, S., Rex, D.A.B., Palollathil, A. et al. A pathway map of AXL receptor-mediated signaling network. J. Cell Commun. Signal. 15, 143–148 (2021). https://doi.org/10.1007/s12079-020-00580-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12079-020-00580-5